TOWA Pharmaceutical Updates Ownership Structure Details

TOKYO, June 24 (Pulse News Wire) – Towa Pharmaceutical CO.,LTD. (4553.T) disclosed updates on its ownership structure involving its related company, Yoshida Office Co., Ltd.

As of March 31, 2026, Yoshida Office Co., Ltd. holds 40.85% of direct voting shares and 4.90% through consolidated holdings, totaling 45.75%. Additionally, Yoshida Office Co., Ltd.

Owns 45.75% of Towa Pharmaceutical's voting rights. Furthermore, Towa Pharmaceutical’s president and CEO, Yoshiro Yoshida, concurrently serves as a director at Yoshida Office Co., Ltd. However, there are no transactions between the companies, and Towa Pharmaceutical maintains its independence due to the absence of any impact on its operations.

Regarding dealings with controlling shareholders, Towa Pharmaceutical reported no such transactions.